Henderson Jane 4
4 · Apogee Therapeutics, Inc. · Filed Nov 14, 2025
Insider Transaction Report
Form 4
Henderson Jane
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-11-14$65.00/sh−2,000$130,000→ 197,871 total
Footnotes (1)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 27, 2024.